Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript

Seagen Inc. (SGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Seagen Phase 3 Trial of TUKYSA ® in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer"
08/02/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/14/2023 8-K Quarterly results
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 SC 13G/A Capital International Investors reports a 3.9% stake in Seagen Inc.
06/07/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/31/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Seagen Stockholders Approve Acquisition by Pfizer"
05/23/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/23/2023 8-K Other Events  Interactive Data
05/16/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/15/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/03/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/01/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 8-K Quarterly results
04/24/2023 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy